Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183937.RA6IwGo4vjwF5rEh6Jgczxy1hkdgl2J4UKcwj5zCj-v0k130_provenance.
• NP218648.RAb2IUPxVwPEes3TD23Mv_IkSBioF9ESaYONg63wadI_o130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP218648.RAb2IUPxVwPEes3TD23Mv_IkSBioF9ESaYONg63wadI_o130_provenance.
• NP920921.RAaGq9H89b3caWRBQH_x_AZj9dzsNKrllUuBLlal6SDvA130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920921.RAaGq9H89b3caWRBQH_x_AZj9dzsNKrllUuBLlal6SDvA130_provenance.
• NP868590.RAZTP6gC3nRI6WC8iCqbbbA2Vi8Qkf4LhRdmH4qSmV2XE130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868590.RAZTP6gC3nRI6WC8iCqbbbA2Vi8Qkf4LhRdmH4qSmV2XE130_provenance.
• NP718972.RAwbq5XcRbbZ0i46vjQcFtwJ_zx9iqmRrAWjeAbgBL8vs130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718972.RAwbq5XcRbbZ0i46vjQcFtwJ_zx9iqmRrAWjeAbgBL8vs130_provenance.
• NP915688.RA5o2MPcRlcIa-UJ3Mfj46D442cNBMkzUJAbO4619m_zg130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915688.RA5o2MPcRlcIa-UJ3Mfj46D442cNBMkzUJAbO4619m_zg130_provenance.
• NP786255.RAXCE7AGrooKto13Et8gU1mqzyf_P8StecmcYP_e2oc1c130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786255.RAXCE7AGrooKto13Et8gU1mqzyf_P8StecmcYP_e2oc1c130_provenance.
• assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP796631.RAdgADImrpzdxdV5r9BuCgSeWHOQbNDSsuN3bfhAVm9sU130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796631.RAdgADImrpzdxdV5r9BuCgSeWHOQbNDSsuN3bfhAVm9sU130_provenance.
• NP796634.RAfRzg5K6-egmDR2JCJvSQBgsszhzsS2YlYUzgFPrhXMk130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796634.RAfRzg5K6-egmDR2JCJvSQBgsszhzsS2YlYUzgFPrhXMk130_provenance.
• NP829063.RAngiAlb8BZVW1bfJ9EeNs7s-rTkEdX0SQNhEC3rO4EGM130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829063.RAngiAlb8BZVW1bfJ9EeNs7s-rTkEdX0SQNhEC3rO4EGM130_provenance.
• NP786231.RAIXdhNjq0rGi2if17SuzAzmmTh1Ljik2CuYIOwgMLxQA130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786231.RAIXdhNjq0rGi2if17SuzAzmmTh1Ljik2CuYIOwgMLxQA130_provenance.
• NP829043.RA8p9wrM8mzMOxm3BOmoCFdW4v27ClFDr394viYIikEhI130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829043.RA8p9wrM8mzMOxm3BOmoCFdW4v27ClFDr394viYIikEhI130_provenance.
• NP796636.RANf_hXSjv0M2YD72FWUHqSNhJsY3STkSHxDOgR2XDB7s130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796636.RANf_hXSjv0M2YD72FWUHqSNhJsY3STkSHxDOgR2XDB7s130_provenance.
• NP796628.RAxlv6qDJYABpYYJhOjsPqYudi-zNjXk6vdHLdwNruwbA130_assertion description "[Gelshift analysis clearly indicated distinct nuclear protein occupancy at this ANXA7-promoter site (-1086/-890) in prostate cancer (LNCaP, DU145, and PC3) versus normal prostate (PrEC) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796628.RAxlv6qDJYABpYYJhOjsPqYudi-zNjXk6vdHLdwNruwbA130_provenance.